Revascularization Practices and Outcomes in Patients With Multivessel Coronary Artery Disease Who Presented With Acute Myocardial Infarction and Cardiogenic Shock in the US, 2009-2018
Author(s) -
Rohan Khera,
Eric A. Secemsky,
Yongfei Wang,
Nihar R. Desai,
Harlan M. Krumholz,
Thomas M. Maddox,
Kendrick Shunk,
Salim S. Virani,
Deepak L. Bhatt,
Jeptha P. Curtis,
Robert W. Yeh
Publication year - 2020
Publication title -
jama internal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.14
H-Index - 342
eISSN - 2168-6114
pISSN - 2168-6106
DOI - 10.1001/jamainternmed.2020.3276
Subject(s) - medicine , cardiogenic shock , conventional pci , myocardial infarction , cardiology , percutaneous coronary intervention , coronary artery disease , culprit , revascularization , population , environmental health
Cardiogenic shock after acute myocardial infarction (AMI) is associated with high mortality, particularly among patients with multivessel coronary artery disease. Recent evidence suggests that use of multivessel percutaneous coronary intervention (PCI) may be associated with harm. However, little is known about recent patterns of care and outcomes for this patient population.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom